Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tempus AI, Inc. before investing.

In this article, we go over a few key elements for understanding Tempus AI, Inc.’s stock price such as:

• Tempus AI, Inc.’s current stock price and volume
• Why Tempus AI, Inc.’s stock price changed recently
• Upgrades and downgrades for TEM from analysts
• TEM’s stock price momentum as measured by its relative strength

About Tempus AI, Inc. (TEM)

Before we jump into Tempus AI, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Want to learn more about Tempus AI, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Tempus AI, Inc..

Tempus AI, Inc.’s Stock Price as of Market Close

As of April 24, 2026, 4:00 PM, CST, Tempus AI, Inc.’s stock price was $52.120.

Tempus AI, Inc. is up 1.32% from its previous closing price of $51.440.

During the last market session, Tempus AI, Inc.’s stock traded between $50.520 and $52.660. Currently, there are approximately 178.15 million shares outstanding for Tempus AI, Inc..

Tempus AI, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Tempus AI, Inc. Stock Price History

Tempus AI, Inc.’s (TEM) price is currently up 15.26% so far this month.

During the month of April, Tempus AI, Inc.’s stock price has reached a high of $58.040 and a low of $42.410.

Over the last year, Tempus AI, Inc. has hit prices as high as $104.320 and as low as $41.730. Year to date, Tempus AI, Inc.’s stock is down 11.74%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Tempus AI, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 24, 2026, there were 0 analysts who downgraded Tempus AI, Inc.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Tempus AI, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Tempus AI, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Tempus AI, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Tempus AI, Inc. (TEM) by visiting AAII Stock Evaluator.

Relative Price Strength of Tempus AI, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 24, 2026, Tempus AI, Inc. has a weighted four-quarter relative price strength of -8.74%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how Tempus AI, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Tempus AI, Inc. Stock Price: Bottom Line

As of April 24, 2026, Tempus AI, Inc.’s stock price is $52.120, which is up 1.32% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Tempus AI, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.